1. Wang, Yishu, Xie, Chong, Song, Yaying, Ding, Jie, Guan, Yangtai. 2021. miR-20a suppresses Treg differentiation by targeting Map3k9 in experimental autoimmune encephalomyelitis. In Journal of translational medicine, 19, 223. doi:10.1186/s12967-021-02893-4. https://pubmed.ncbi.nlm.nih.gov/34039371/
2. Lalaoui, Najoua, Boyden, Steven E, Oda, Hirotsugu, Kastner, Daniel L, Silke, John. 2019. Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease. In Nature, 577, 103-108. doi:10.1038/s41586-019-1828-5. https://pubmed.ncbi.nlm.nih.gov/31827281/
3. Chen, Xiao-Yu, Yang, Yan-Ling, Yu, Yi, Zhang, Jing, Zhu, Jin-Shui. 2024. CircUGGT2 downregulation by METTL14-dependent m6A modification suppresses gastric cancer progression and cisplatin resistance through interaction with miR-186-3p/MAP3K9 axis. In Pharmacological research, 204, 107206. doi:10.1016/j.phrs.2024.107206. https://pubmed.ncbi.nlm.nih.gov/38729588/
4. Ma, Xinhao, Zhang, Dianqi, Yang, Zhimei, Mei, Chugang, Zan, Linsen. 2024. Bta-miR-484 regulates proliferation and apoptosis of bovine intramuscular preadipocytes via targeting MAP3K9 to inhibit the JNK signaling pathway. In International journal of biological macromolecules, 286, 138082. doi:10.1016/j.ijbiomac.2024.138082. https://pubmed.ncbi.nlm.nih.gov/39603290/
5. Jun, Liu, Xuhong, Li, Hui, Liu. 2020. Circ_SIPA1L1 Promotes Osteosarcoma Progression Via miR-379-5p/MAP3K9 Axis. In Cancer biotherapy & radiopharmaceuticals, 38, 604-618. doi:10.1089/cbr.2020.3891. https://pubmed.ncbi.nlm.nih.gov/32897735/
6. Ma, Xinhao, Zhang, Dianqi, Yang, Zhimei, Mei, Chugang, Zan, Linsen. 2024. bta-miR-484 Inhibits Bovine Intramuscular Adipogenesis by Regulating Mitotic Clonal Expansion via the MAP3K9/JNK/CCND1 Axis. In Journal of agricultural and food chemistry, 73, 1062-1074. doi:10.1021/acs.jafc.4c07956. https://pubmed.ncbi.nlm.nih.gov/39719059/
7. Ren, Qingbo, Xiao, Xiangmei, Leng, Xiaoqian, Ren, Ziyuan, Xiao, Hang. 2021. MicroRNA-361-5p induces hepatocellular carcinoma cell apoptosis and enhances drug sensitivity by targeting MAP3K9. In Experimental and therapeutic medicine, 21, 574. doi:10.3892/etm.2021.10006. https://pubmed.ncbi.nlm.nih.gov/33850546/
8. Liang, Lu, Xu, Wen-Yan, Shen, Ao, Huang, Jiong-Hua, Yu, Xi-Yong. 2022. Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9. In Acta pharmacologica Sinica, 43, 2946-2955. doi:10.1038/s41401-022-00893-8. https://pubmed.ncbi.nlm.nih.gov/35388129/
9. Zhang, B-X, Yu, T, Yu, Z, Yang, X-G. . MicroRNA-148a regulates the MAPK/ERK signaling pathway and suppresses the development of esophagus squamous cell carcinoma via targeting MAP3K9. In European review for medical and pharmacological sciences, 23, 6497-6504. doi:10.26355/eurrev_201908_18533. https://pubmed.ncbi.nlm.nih.gov/31378889/
智鼠故事 
